Summary:
Have you been diagnosed with advanced breast cancer?
FALCON, a Phase III global clinical trial is enrolling patients with hormone receptor-positive advanced breast cancer. You may be eligible if you:
- Are postmenopausal
- Have hormone receptor-positive locally advanced or metastatic breast cancer
- Have not received prior hormonal therapy for breast cancer
The FALCON Study is comparing two established and widely-used treatments for breast cancer. Both treatments have been approved in the USA by the Food and Drug Administration (FDA) but they have not been directly compared before as a first line of treatment in a large number of patients with breast cancer.